1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow RO4602522: new trials by email Literature Review of RO4602522 trials Research Report on RO4602522
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy RO4602522, Placebo, Donepezil - Alzheimer's Disease | Phase 2 | Completed | Hoffmann-La Roche | 542 | 2012-10-24 | 2017-05-30 |
Australia (1) · Canada (1) · Czechia (1) · France (1) · Germany (1) · Italy (1) · Poland (1) · South Korea (1) · Spain (1) · Sweden (1) · United Kingdom (1) · United States (1)